| scholarly article | Q13442814 |
| P356 | DOI | 10.1074/JBC.271.37.22641 |
| P698 | PubMed publication ID | 8798435 |
| P2093 | author name string | E P Loret | |
| C J Gregoire | |||
| P2860 | cites work | NMR structure of a biologically active peptide containing the RNA-binding domain of human immunodeficiency virus type 1 Tat | Q24564152 |
| Solution structure of a bovine immunodeficiency virus Tat-TAR peptide-RNA complex | Q27729342 | ||
| Structural studies of HIV-1 Tat protein | Q27730186 | ||
| The Protein Data Bank: a computer-based archival file for macromolecular structures | Q27860989 | ||
| Repression of MHC class I gene promoter activity by two-exon Tat of HIV | Q28269206 | ||
| Empirical Predictions of Protein Conformation | Q28300310 | ||
| Control of RNA initiation and elongation at the HIV-1 promoter | Q29620157 | ||
| HIV-1 Tat protein trans-activates transcription in vitro | Q30411837 | ||
| Sequence-specific interaction of Tat protein and Tat peptides with the transactivation-responsive sequence element of human immunodeficiency virus type 1 in vitro | Q33900660 | ||
| Human immunodeficiency virus 1 tat protein binds trans-activation-responsive region (TAR) RNA in vitro | Q34303073 | ||
| Multiple functional domains of Tat, the trans-activator of HIV-1, defined by mutational analysis | Q35226113 | ||
| Circular dichroism and molecular modeling yield a structure for the complex of human immunodeficiency virus type 1 trans-activation response RNA and the binding region of Tat, the trans-acting transcriptional activator | Q37251783 | ||
| The HIV-1 Tat protein: an RNA sequence-specific processivity factor? | Q37976427 | ||
| Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. | Q41335848 | ||
| Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein | Q41349382 | ||
| Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma | Q41435232 | ||
| High affinity binding of TAR RNA by the human immunodeficiency virus type-1 tat protein requires base-pairs in the RNA stem and amino acid residues flanking the basic region | Q43480910 | ||
| Arginine-mediated RNA recognition: the arginine fork. | Q44511258 | ||
| Analysis of arginine-rich peptides from the HIV Tat protein reveals unusual features of RNA-protein recognition | Q44540333 | ||
| Fragments of the HIV-1 Tat protein specifically bind TAR RNA. | Q45148606 | ||
| Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein | Q45830211 | ||
| Trans-activation of human immunodeficiency virus occurs via a bimodal mechanism | Q45830933 | ||
| Trans-activator gene of human T-lymphotropic virus type III (HTLV-III). | Q45838520 | ||
| Tat protein from human immunodeficiency virus forms a metal-linked dimer | Q45841752 | ||
| HIV-1 TAT "activates" presynthesized RNA in the nucleus | Q48291503 | ||
| RNA recognition by Tat-derived peptides: interaction in the major groove? | Q50134622 | ||
| Conformation of the TAR RNA-Arginine Complex by NMR Spectroscopy | Q68188961 | ||
| Variable selection method improves the prediction of protein secondary structure from circular dichroism spectra | Q68554855 | ||
| A bulge structure in HIV-1 TAR RNA is required for Tat binding and Tat-mediated trans-activation | Q68583028 | ||
| Mapping of HIV-1 Tat protein sequences required for binding to Tar RNA | Q70145530 | ||
| Activating region of HIV-1 Tat protein: vacuum UV circular dichroism and energy minimization | Q70176147 | ||
| Importance of environment in determining secondary structure in proteins | Q72266480 | ||
| Halogenation of tyrosine during acid hydrolysis | Q79613483 | ||
| P433 | issue | 37 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | heterogeneity | Q928498 |
| P304 | page(s) | 22641-22646 | |
| P577 | publication date | 1996-09-01 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Conformational heterogeneity in two regions of TAT results in structural variations of this protein as a function of HIV-1 isolates | |
| P478 | volume | 271 |
| Q27628699 | 1H-13C nuclear magnetic resonance assignment and structural characterization of HIV-1 Tat protein |
| Q43973641 | A designed Tat immunogen generates enhanced anti-Tat C-terminal antibodies |
| Q46361892 | Full peptide synthesis, purification, and characterization of six Tat variants. Differences observed between HIV-1 isolates from Africa and other continents |
| Q41468434 | Identification of a highly conserved surface on Tat variants |
| Q34488930 | Reservoir cells no longer detectable after a heterologous SHIV challenge with the synthetic HIV-1 Tat Oyi vaccine. |
| Q34033142 | Tat as a transcriptional activator and a potential therapeutic target for HIV-1. |
| Q43822559 | The basic domain in HIV-1 Tat protein as a target for polysulfonated heparin-mimicking extracellular Tat antagonists |
| Q37220038 | What does the structure-function relationship of the HIV-1 Tat protein teach us about developing an AIDS vaccine? |
Search more.